About Us

Who We Are

Stem Cell Theranostics (SCT) is a Silicon Valley Biotechnology Company that was launched in 2013 to commercialize the breakthroughs perfected at Stanford University School of Medicine for use of patient-specific stem cells in personalized medicine. SCT’s core technology focuses on the generation and use of patient-specific stem cells in drug screening and therapeutic development. Our initial product, a “Clinical Trial in a Dish” drug screening platform, was developed at Stanford over the past decade by SCT’s world-renowned founders- Dr. Joseph Wu, Dr. Robert Robbins, and Dr. Andrew Lee.